Back
Enterprise Financial Services Vs. Summit Therapeutics Industry Stock Comparison
Sell
50
EFSC
Enterprise Financial Services
Last Price:
51.78
Seasonality Move:
6.3%
Buy
79
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Sell
50
Enterprise Financial Services (EFSC)
is a Sell
Is Enterprise Financial Services a Buy, Sell or Hold?
- The current Enterprise Financial Services [EFSC] share price is $52.11. The Score for EFSC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- EFSC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EFSC Stock Price Chart
What is Enterprise Financial Services's stock price today?
-
The Enterprise Financial Services share price today is $52.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFSC is experiencing slight selling pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.22
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
EFSC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.53 | Buy |
Relative Strength Index (14 RSI): | 59.99 | Buy |
Chaikin Money Flow: | -20559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.55 - 52.27) | Buy |
Bollinger Bands (100): | (38.46 - 50.18) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.4 | Buy |
Relative Strength Index (14 RSI): | 69.61 | Buy |
Chaikin Money Flow: | -7453022 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.89 - 22.53) | Buy |
Bollinger Bands (100): | (4.23 - 14.99) | Buy |
EFSC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.84 | Buy |
20-day SMA: | 51.34 | Buy |
50-day SMA: | 49.66 | Buy |
200-day SMA: | 42.68 | Buy |
8-day EMA: | 51.21 | Buy |
20-day EMA: | 50.92 | Buy |
50-day EMA: | 48.92 | Buy |
200-day EMA: | 43.88 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.01 | Buy |
20-day SMA: | 17.36 | Buy |
50-day SMA: | 13.03 | Buy |
200-day SMA: | 6.61 | Buy |
8-day EMA: | 24.48 | Buy |
20-day EMA: | 19.28 | Buy |
50-day EMA: | 14.43 | Buy |
200-day EMA: | 8.04 | Buy |
Enterprise Financial Services Earnings Growth & EFSC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.07 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Enterprise Financial Services Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |